Revolution Medicines, Inc. - Common Stock —— 季度资产负债表 (NASDAQ:RVMD) | MetaTrader

展开完整图表完整图表

新闻

Revolution Medicines' Pancreatic Cancer Pill Doubles Survival, Cuts Death Risk 60% in Trial As Stock Sits

Tango Therapeutics: 'Hold' On Combination Strategy Shift Of Vopimetostat (NASDAQ:TNGX)

Top Research Reports for Home Depot, TJX & Marvell Technology

Erasca: "Hold" On Substantial RAS Targeting ERAS-0015 But With Two Key Risks (NASDAQ:ERAS)

RVMD Reports Wider-Than-Expected Loss in Q1, Raises '26 Expense View

Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone

Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?

Why This CEO Is Confident His Drug Can Top 'Unprecedented' Pancreatic Cancer Results

Why Erasca, Up 415% This Year Amid Revolution-Tied Furor, Just Lost Half Its Value

There’s a Revolution in Cancer. But Can Big Pharma Afford It?

Stock Market Hits Highs On Iran Hopes; Goldman Sachs, Netflix, Taiwan Semiconductor In Focus: Weekly Review

Revolution Medicines: "Strong Buy" On Daraxonrasib Win And Expansions Underway (RVMD)